N
← Back to Search
Sponsored

Accelerate Your Clinical Trial Recruitment

Reach thousands of high-intent patients matching your specific inclusion criteria.

Start Campaign
RECRUITING Phase 3 ClinicalTrials.gov

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

Sponsor: Alnylam Pharmaceuticals • ClinicalTrials.gov ID: NCT07181109

Registry updated: 2026-10-15
Ad

Recruiting for Similar Conditions?

Sponsors are looking for patients like you. See if you qualify for compensated research studies.

Check Eligibility →

Description

The purpose of this study is to evaluate whether zilebesiran versus placebo reduces the risk of cardiovascular (CV) death, nonfatal myocardial infarction (MI), nonfatal stroke, or heart failure (HF) events. This is an event-driven study that will continue until the targeted number of positively adjudicated primary endpoint clinical outcome events (COEs) have been reached.

Interventions

  • Zilebesiran (Drug)
    Zilebesiran will be administered SC
  • Placebo (Drug)
    Placebo will be administered SC

Eligibility criteria

Inclusion Criteria: * Is 18 years or older for patients with established cardiovascular disease (CVD) * Is 55 years or older for patients with high risk for CVD * Has established CVD (defined as coronary, cerebrovascular, or peripheral artery disease) or high risk for CVD * Has treated hypertension on stable therapy with at least 2 standard of care antihypertensive medications, one of which must be a thiazide, thiazide-like, or loop diuretic Exclusion Criteria: * Has known history of secondary hypertension * Has symptomatic orthostatic hypotension * Has alanine aminotransferase (ALT) or aspartate aminotransferase (AST) \>3×upper limit of normal (ULN) * Has total serum bilirubin \>1.5×ULN * Has international normalized ratio (INR) \>1.5 * Has serum potassium \>4.8 mEq/L * Has estimated glomerular filtration rate (eGFR) \<30 mL/min/1.73m\^2

Conditions

High Risk Cardiovascular Disease Hypertension High Cardiovascular Risk

Locations

  • Clinical Trial Site — Birmingham, Alabama, United States
  • Clinical Trial Site — Birmingham, Alabama, United States
  • Clinical Trial Site — Fairhope, Alabama, United States
  • Clinical Trial Site — Foley, Alabama, United States
  • Clinical Trial Site — Huntsville, Alabama, United States
  • Clinical Trial Site — Huntsville, Alabama, United States
  • Clinical Trial Site — Sheffield, Alabama, United States
  • Clinical Trial Site — Chandler, Arizona, United States
  • Clinical Trial Site — Gilbert, Arizona, United States
  • Clinical Trial Site — Glendale, Arizona, United States
  • Clinical Trial Site — Mesa, Arizona, United States
  • Clinical Trial Site — Phoenix, Arizona, United States
  • Clinical Trial Site — Phoenix, Arizona, United States
  • Clinical Trial Site — Sun City, Arizona, United States
  • Clinical Trial Site — Sun City West, Arizona, United States
  • Clinical Trial Site — Tempe, Arizona, United States
  • Clinical Trial Site — Tucson, Arizona, United States
  • Clinical Trial Site — Tucson, Arizona, United States
  • Clinical Trial Site — Yuma, Arizona, United States
  • Clinical Trial Site — Little Rock, Arkansas, United States
  • Clinical Trial Site — Little Rock, Arkansas, United States
  • Clinical Trial Site — Beverly Hills, California, United States
  • Clinical Trial Site — Chula Vista, California, United States
  • Clinical Trial Site — Covina, California, United States
  • Clinical Trial Site — Escondido, California, United States
  • Clinical Trial Site — Glendale, California, United States
  • Clinical Trial Site — Huntington Beach, California, United States
  • Clinical Trial Site — La Jolla, California, United States
  • Clinical Trial Site — Lancaster, California, United States
  • Clinical Trial Site — Long Beach, California, United States
  • Clinical Trial Site — Lynwood, California, United States
  • Clinical Trial Site — Newhall, California, United States
  • Clinical Trial Site — Northridge, California, United States
  • Clinical Trial Site — Pasadena, California, United States
  • Clinical Trial Site — San Diego, California, United States
  • Clinical Trial Site — San Dimas, California, United States
  • Clinical Trial Site — San Ramon, California, United States
  • Clinical Trial Site — Stockton, California, United States
  • Clinical Trial Site — Tarzana, California, United States
  • Clinical Trial Site — Toluca Lake, California, United States
  • Clinical Trial Site — Torrance, California, United States
  • Clinical Trial Site — Tustin, California, United States
  • Clinical Trial Site — Vista, California, United States
  • Clinical Trial Site — Walnut Creek, California, United States
  • Clinical Trial Site — Wheat Ridge, Colorado, United States
  • Clinical Trial Site — Bridgeport, Connecticut, United States
  • Clinical Trial Site — Waterbury, Connecticut, United States
  • Clinical Trial Site — Boca Raton, Florida, United States
  • Clinical Trial Site — Brandon, Florida, United States
  • Clinical Trial Site — Fleming Island, Florida, United States
  • Clinical Trial Site — Fort Lauderdale, Florida, United States
  • Clinical Trial Site — Hialeah, Florida, United States
  • Clinical Trial Site — Hollywood, Florida, United States
  • Clinical Trial Site — Homestead, Florida, United States
  • Clinical Trial Site — Jacksonville, Florida, United States
  • Clinical Trial Site — Jacksonville, Florida, United States
  • Clinical Trial Site — Jacksonville, Florida, United States
  • Clinical Trial Site — Jensen Beach, Florida, United States
  • Clinical Trial Site — Leesburg, Florida, United States
  • Clinical Trial Site — Melbourne, Florida, United States
  • Clinical Trial Site — Miami, Florida, United States
  • Clinical Trial Site — Miami, Florida, United States
  • Clinical Trial Site — Miami, Florida, United States
  • Clinical Trial Site — Miami, Florida, United States
  • Clinical Trial Site — Miami, Florida, United States
  • Clinical Trial Site — Miami, Florida, United States
  • Clinical Trial Site — Orlando, Florida, United States
  • Clinical Trial Site — Palm Springs, Florida, United States
  • Clinical Trial Site — Tampa, Florida, United States
  • Clinical Trial Site — Tampa, Florida, United States
  • Clinical Trial Site — Wellington, Florida, United States
  • Clinical Trial Site — Winter Park, Florida, United States
  • Clinical Trial Site — Atlanta, Georgia, United States
  • Clinical Trial Site — Atlanta, Georgia, United States
  • Clinical Trial Site — Atlanta, Georgia, United States
  • Clinical Trial Site — Brunswick, Georgia, United States
  • Clinical Trial Site — Canton, Georgia, United States
  • Clinical Trial Site — Columbus, Georgia, United States
  • Clinical Trial Site — Columbus, Georgia, United States
  • Clinical Trial Site — Conyers, Georgia, United States
  • Clinical Trial Site — Conyers, Georgia, United States
  • Clinical Trial Site — Fayetteville, Georgia, United States
  • Clinical Trial Site — Hinesville, Georgia, United States
  • Clinical Trial Site — Johns Creek, Georgia, United States
  • Clinical Trial Site — Lawrenceville, Georgia, United States
  • Clinical Trial Site — Macon, Georgia, United States
  • Clinical Trial Site — Stonecrest, Georgia, United States
  • Clinical Trial Site — Suwanee, Georgia, United States
  • Clinical Trial Site — Thomasville, Georgia, United States
  • Clinical Trial Site — Arlington Heights, Illinois, United States
  • Clinical Trial Site — Chicago, Illinois, United States
  • Clinical Trial Site — Chicago, Illinois, United States
  • Clinical Trial Site — Hazel Crest, Illinois, United States
  • Clinical Trial Site — Oak Brook, Illinois, United States
  • Clinical Trial Site — Orland Park, Illinois, United States
  • Clinical Trial Site — Peoria, Illinois, United States
  • Clinical Trial Site — Springfield, Illinois, United States
  • Clinical Trial Site — Tinley Park, Illinois, United States
  • Clinical Trial Site — Avon, Indiana, United States
  • Clinical Trial Site — Carmel, Indiana, United States
  • Clinical Trial Site — Evansville, Indiana, United States
  • Clinical Trial Site — Evansville, Indiana, United States
  • Clinical Trial Site — Greenfield, Indiana, United States
  • Clinical Trial Site — South Bend, Indiana, United States
  • Clinical Trial Site — Valparaiso, Indiana, United States
  • Clinical Trial Site — Whiteland, Indiana, United States
  • Clinical Trial Site — Hutchinson, Kansas, United States
  • Clinical Trial Site — Kansas City, Kansas, United States
  • Clinical Trial Site — Topeka, Kansas, United States
  • Clinical Trial Site — Wichita, Kansas, United States
  • Clinical Trial Site — Wichita, Kansas, United States
  • Clinical Trial Site — Bowling Green, Kentucky, United States
  • Clinical Trial Site — Lexington, Kentucky, United States
  • Clinical Trial Site — Versailles, Kentucky, United States
  • Clinical Trial Site — Hammond, Louisiana, United States
  • Clinical Trial Site — Lafayette, Louisiana, United States
  • Clinical Trial Site — Metairie, Louisiana, United States
  • Clinical Trial Site — New Orleans, Louisiana, United States
  • Clinical Trial Site — Opelousas, Louisiana, United States
  • Clinical Trial Site — Shreveport, Louisiana, United States
  • Clinical Trial Site — Slidell, Louisiana, United States
  • Clinical Trial Site — Zachary, Louisiana, United States
  • Clinical Trial Site — Baltimore, Maryland, United States
  • Clinical Trial Site — Baltimore, Maryland, United States
  • Clinical Trial Site — Baltimore, Maryland, United States
  • Clinical Trial Site — Beltsville, Maryland, United States
  • Clinical Trial Site — Bowie, Maryland, United States
  • Clinical Trial Site — Lanham, Maryland, United States
  • Clinical Trial Site — Rockville, Maryland, United States
  • Clinical Trial Site — Flint, Michigan, United States
  • Clinical Trial Site — Lansing, Michigan, United States
  • Clinical Trial Site — Midland, Michigan, United States
  • Clinical Trial Site — Petoskey, Michigan, United States
  • Clinical Trial Site — Shelby, Michigan, United States
  • Clinical Trial Site — Southfield, Michigan, United States
  • Clinical Trial Site — Troy, Michigan, United States
  • Clinical Trial Site — Troy, Michigan, United States
  • Clinical Trial Site — Richfield, Minnesota, United States
  • Clinical Trial Site — Saint Cloud, Minnesota, United States
  • Clinical Trial Site — Saint Paul, Minnesota, United States
  • Clinical Trial Site — Jackson, Mississippi, United States
  • Clinical Trial Site — Olive Branch, Mississippi, United States
  • Clinical Trial Site — Port Gibson, Mississippi, United States
  • Clinical Trial Site — Ridgeland, Mississippi, United States
  • Clinical Trial Site — Tupelo, Mississippi, United States
  • Clinical Trial Site — Kansas City, Missouri, United States
  • Clinical Trial Site — Kansas City, Missouri, United States
  • Clinical Trial Site — Kansas City, Missouri, United States
  • Clinical Trial Site — St Louis, Missouri, United States
  • Clinical Trial Site — St Louis, Missouri, United States
  • Clinical Trial Site — Fremont, Nebraska, United States
  • Clinical Trial Site — Omaha, Nebraska, United States
  • Clinical Trial Site — Las Vegas, Nevada, United States
  • Clinical Trial Site — Las Vegas, Nevada, United States
  • Clinical Trial Site — Las Vegas, Nevada, United States
  • Clinical Trial Site — Las Vegas, Nevada, United States
  • Clinical Trial Site — Portsmouth, New Hampshire, United States
  • Clinical Trial Site — Brick, New Jersey, United States
  • Clinical Trial Site — Bridgewater, New Jersey, United States
  • Clinical Trial Site — Flemington, New Jersey, United States
  • Clinical Trial Site — Albuquerque, New Mexico, United States
  • Clinical Trial Site — New Windsor, New York, United States
  • Clinical Trial Site — North Massapequa, New York, United States
  • Clinical Trial Site — Poughkeepsie, New York, United States
  • Clinical Trial Site — Riverhead, New York, United States
  • Clinical Trial Site — Rosedale, New York, United States
  • Clinical Trial Site — Saratoga Springs, New York, United States
  • Clinical Trial Site — Stony Brook, New York, United States
  • Clinical Trial Site — The Bronx, New York, United States
  • Clinical Trial Site — West Seneca, New York, United States
  • Clinical Trial Site — Westfield, New York, United States
  • Clinical Trial Site — Durham, North Carolina, United States
  • Clinical Trial Site — Greenville, North Carolina, United States
  • Clinical Trial Site — High Point, North Carolina, United States
  • Clinical Trial Site — Jacksonville, North Carolina, United States
  • Clinical Trial Site — Kings Mountain, North Carolina, United States
  • Clinical Trial Site — Monroe, North Carolina, United States
  • Clinical Trial Site — Statesville, North Carolina, United States
  • Clinical Trial Site — Winston-Salem, North Carolina, United States
  • Clinical Trial Site — Fargo, North Dakota, United States
  • Clinical Trial Site — Beavercreek, Ohio, United States
  • Clinical Trial Site — Cincinnati, Ohio, United States
  • Clinical Trial Site — Cincinnati, Ohio, United States
  • Clinical Trial Site — Columbus, Ohio, United States
  • Clinical Trial Site — Columbus, Ohio, United States
  • Clinical Trial Site — Dayton, Ohio, United States
  • Clinical Trial Site — Dayton, Ohio, United States
  • Clinical Trial Site — Lima, Ohio, United States
  • Clinical Trial Site — Maumee, Ohio, United States
  • Clinical Trial Site — Moraine, Ohio, United States
  • Clinical Trial Site — Edmond, Oklahoma, United States
  • Clinical Trial Site — Moore, Oklahoma, United States
  • Clinical Trial Site — Norman, Oklahoma, United States
  • Clinical Trial Site — Oklahoma City, Oklahoma, United States
  • Clinical Trial Site — Camp Hill, Pennsylvania, United States
  • Clinical Trial Site — Danville, Pennsylvania, United States
  • Clinical Trial Site — Horsham, Pennsylvania, United States
  • Clinical Trial Site — Linwood, Pennsylvania, United States
  • Clinical Trial Site — Media, Pennsylvania, United States
  • Clinical Trial Site — Philadelphia, Pennsylvania, United States
  • Clinical Trial Site — Uniontown, Pennsylvania, United States
  • Clinical Trial Site — Charleston, South Carolina, United States
  • Clinical Trial Site — Columbia, South Carolina, United States
  • Clinical Trial Site — Greenville, South Carolina, United States
  • Clinical Trial Site — Greer, South Carolina, United States
  • Clinical Trial Site — Sioux Falls, South Dakota, United States
  • Clinical Trial Site — Chattanooga, Tennessee, United States
  • Clinical Trial Site — Chattanooga, Tennessee, United States
  • Clinical Trial Site — Knoxville, Tennessee, United States
  • Clinical Trial Site — Knoxville, Tennessee, United States
  • Clinical Trial Site — Allen, Texas, United States
  • Clinical Trial Site — Amarillo, Texas, United States
  • Clinical Trial Site — Amarillo, Texas, United States
  • Clinical Trial Site — Arlington, Texas, United States
  • Clinical Trial Site — Arlington, Texas, United States
  • Clinical Trial Site — Austin, Texas, United States
  • Clinical Trial Site — Austin, Texas, United States
  • Clinical Trial Site — Beaumont, Texas, United States
  • Clinical Trial Site — Carrollton, Texas, United States
  • Clinical Trial Site — Dallas, Texas, United States
  • Clinical Trial Site — Dallas, Texas, United States
  • Clinical Trial Site — Dallas, Texas, United States
  • Clinical Trial Site — Duncanville, Texas, United States
  • Clinical Trial Site — El Paso, Texas, United States
  • Clinical Trial Site — El Paso, Texas, United States
  • Clinical Trial Site — Euless, Texas, United States
  • Clinical Trial Site — Houston, Texas, United States
  • Clinical Trial Site — Houston, Texas, United States
  • Clinical Trial Site — Houston, Texas, United States
  • Clinical Trial Site — Houston, Texas, United States
  • Clinical Trial Site — Houston, Texas, United States
  • Clinical Trial Site — Houston, Texas, United States
  • Clinical Trial Site — Houston, Texas, United States
  • Clinical Trial Site — Houston, Texas, United States
  • Clinical Trial Site — Houston, Texas, United States
  • Clinical Trial Site — Humble, Texas, United States
  • Clinical Trial Site — Katy, Texas, United States
  • Clinical Trial Site — Kingwood, Texas, United States
  • Clinical Trial Site — Laredo, Texas, United States
  • Clinical Trial Site — McAllen, Texas, United States
  • Clinical Trial Site — McKinney, Texas, United States
  • Clinical Trial Site — McKinney, Texas, United States
  • Clinical Trial Site — Mesquite, Texas, United States
  • Clinical Trial Site — Missouri City, Texas, United States
  • Clinical Trial Site — Paris, Texas, United States
  • Clinical Trial Site — Pasadena, Texas, United States
  • Clinical Trial Site — Plano, Texas, United States
  • Clinical Trial Site — Port Arthur, Texas, United States
  • Clinical Trial Site — San Antonio, Texas, United States
  • Clinical Trial Site — San Antonio, Texas, United States
  • Clinical Trial Site — San Antonio, Texas, United States
  • Clinical Trial Site — San Antonio, Texas, United States
  • Clinical Trial Site — Sherman, Texas, United States
  • Clinical Trial Site — Sugar Land, Texas, United States
  • Clinical Trial Site — Tomball, Texas, United States
  • Clinical Trial Site — Waco, Texas, United States
  • Clinical Trial Site — Bountiful, Utah, United States
  • Clinical Trial Site — Bountiful, Utah, United States
  • Clinical Trial Site — Layton, Utah, United States
  • Clinical Trial Site — Salt Lake City, Utah, United States
  • Clinical Trial Site — Arlington, Virginia, United States
  • Clinical Trial Site — Danville, Virginia, United States
  • Clinical Trial Site — Fairfax, Virginia, United States
  • Clinical Trial Site — Falls Church, Virginia, United States
  • Clinical Trial Site — Manassas, Virginia, United States
  • Clinical Trial Site — Newport News, Virginia, United States
  • Clinical Trial Site — Norfolk, Virginia, United States
  • Clinical Trial Site — Richmond, Virginia, United States
  • Clinical Trial Site — Richmond, Virginia, United States
  • Clinical Trial Site — Suffolk, Virginia, United States
  • Clinical Trial Site — Winchester, Virginia, United States
  • Clinical Trial Site — Bellevue, Washington, United States
  • Clinical Trial Site — Kenosha, Wisconsin, United States
  • Clinical Trial Site — Bahía Blanca, Argentina
  • Clinical Trial Site — Bahía Blanca, Argentina
  • Clinical Trial Site — Buenos Aires, Argentina
  • Clinical Trial Site — Buenos Aires, Argentina
  • Clinical Trial Site — Buenos Aires, Argentina
  • Clinical Trial Site — Buenos Aires, Argentina
  • Clinical Trial Site — Buenos Aires, Argentina
  • Clinical Trial Site — Buenos Aires, Argentina
  • Clinical Trial Site — Buenos Aires, Argentina
  • Clinical Trial Site — Buenos Aires, Argentina
  • Clinical Trial Site — Buenos Aires, Argentina
  • Clinical Trial Site — Buenos Aires, Argentina
  • Clinical Trial Site — Buenos Aires, Argentina
  • Clinical Trial Site — Buenos Aires, Argentina
  • Clinical Trial Site — Buenos Aires, Argentina
  • Clinical Trial Site — Buenos Aires, Argentina
  • Clinical Trial Site — Buenos Aires, Argentina
  • Clinical Trial Site — Ciudad Autónoma Buenos Aires, Argentina
  • Clinical Trial Site — Ciudadela, Argentina
  • Clinical Trial Site — Coronel Suárez, Argentina
  • Clinical Trial Site — Corrientes, Argentina
  • Clinical Trial Site — Córdoba, Argentina
  • Clinical Trial Site — Córdoba, Argentina
  • Clinical Trial Site — Córdoba, Argentina
  • Clinical Trial Site — Córdoba, Argentina
  • Clinical Trial Site — Córdoba, Argentina
  • Clinical Trial Site — Córdoba, Argentina
  • Clinical Trial Site — Córdoba, Argentina
  • Clinical Trial Site — Córdoba, Argentina
  • Clinical Trial Site — Córdoba, Argentina
  • Clinical Trial Site — Córdoba, Argentina
  • Clinical Trial Site — Córdoba, Argentina
  • Clinical Trial Site — Córdoba, Argentina
  • Clinical Trial Site — Esperanza, Argentina
  • Clinical Trial Site — Formosa, Argentina
  • Clinical Trial Site — General San Martín, Argentina
  • Clinical Trial Site — Granadero Baigorria, Argentina
  • Clinical Trial Site — Lanús Este, Argentina
  • Clinical Trial Site — Mar del Plata, Argentina
  • Clinical Trial Site — Mar del Plata, Argentina
  • Clinical Trial Site — Morón, Argentina
  • Clinical Trial Site — Quilmes, Argentina
  • Clinical Trial Site — Ramos Mejía, Argentina
  • Clinical Trial Site — Río Cuarto, Argentina
  • Clinical Trial Site — Rosario, Argentina
  • Clinical Trial Site — Rosario, Argentina
  • Clinical Trial Site — Rosario, Argentina
  • Clinical Trial Site — Rosario, Argentina
  • Clinical Trial Site — Rosario, Argentina
  • Clinical Trial Site — Rosario, Argentina
  • Clinical Trial Site — Rosario, Argentina
  • Clinical Trial Site — Salta, Argentina
  • Clinical Trial Site — Salta, Argentina
  • Clinical Trial Site — San Juan Bautista, Argentina
  • Clinical Trial Site — San Miguel de Tucumán, Argentina
  • Clinical Trial Site — San Miguel de Tucumán, Argentina
  • Clinical Trial Site — San Miguel de Tucumán, Argentina
  • Clinical Trial Site — San Miguel de Tucumán, Argentina
  • Clinical Trial Site — San Nicolás de los Arroyos, Argentina
  • Clinical Trial Site — San Nicolás de los Arroyos, Argentina
  • Clinical Trial Site — Santa Fe, Argentina
  • Clinical Trial Site — Santa Fe, Argentina
  • Clinical Trial Site — Santa Fe, Argentina
  • Clinical Trial Site — Temperley, Argentina
  • Clinical Trial Site — Villa María, Argentina
  • Clinical Trial Site — Auchenflower, Australia
  • Clinical Trial Site — Brisbane, Australia
  • Clinical Trial Site — Brookvale, Australia
  • Clinical Trial Site — Castle Hill, Australia
  • Clinical Trial Site — Clayton, Australia
  • Clinical Trial Site — Concord, Australia
  • Clinical Trial Site — Douglas, Australia
  • Clinical Trial Site — Gosford, Australia
  • Clinical Trial Site — Kogarah, Australia
  • Clinical Trial Site — Leabrook, Australia
  • Clinical Trial Site — Merewether, Australia
  • Clinical Trial Site — Milton, Australia
  • Clinical Trial Site — Sippy Downs, Australia
  • Clinical Trial Site — Southport, Australia
  • Clinical Trial Site — Southport, Australia
  • Clinical Trial Site — St Albans, Australia
  • Clinical Trial Site — Tarragindi, Australia
  • Clinical Trial Site — Waitara, Australia
  • Clinical Trial Site — Braunau am Inn, Austria
  • Clinical Trial Site — Graz, Austria
  • Clinical Trial Site — Linz, Austria
  • Clinical Trial Site — Saint Stefan Ob Stainz, Austria
  • Clinical Trial Site — Salzburg, Austria
  • Clinical Trial Site — Vienna, Austria
  • Clinical Trial Site — Vienna, Austria
  • Clinical Trial Site — Vienna, Austria
  • Clinical Trial Site — Vienna, Austria
  • Clinical Trial Site — Vienna, Austria
  • Clinical Trial Site — Aalst, Belgium
  • Clinical Trial Site — Bonheiden, Belgium
  • Clinical Trial Site — Brasschaat, Belgium
  • Clinical Trial Site — Bruges, Belgium
  • Clinical Trial Site — Brussels, Belgium
  • Clinical Trial Site — Dendermonde, Belgium
  • Clinical Trial Site — Erpent, Belgium
  • Clinical Trial Site — Genk, Belgium
  • Clinical Trial Site — Ghent, Belgium
  • Clinical Trial Site — Hasselt, Belgium
  • Clinical Trial Site — Huy, Belgium
  • Clinical Trial Site — Ieper, Belgium
  • Clinical Trial Site — Kortrijk, Belgium
  • Clinical Trial Site — Leuven, Belgium
  • Clinical Trial Site — Liège, Belgium
  • Clinical Trial Site — Ostend, Belgium
  • Clinical Trial Site — Roeselare, Belgium
  • Clinical Trial Site — Ronse, Belgium
  • Clinical Trial Site — Yvoir, Belgium
  • Clinical Trial Site — Aracaju, Brazil
  • Clinical Trial Site — Aracaju, Brazil
  • Clinical Trial Site — Belo Horizonte, Brazil
  • Clinical Trial Site — Belo Horizonte, Brazil
  • Clinical Trial Site — Belo Horizonte, Brazil
  • Clinical Trial Site — Belo Horizonte, Brazil
  • Clinical Trial Site — Blumenau, Brazil
  • Clinical Trial Site — Botucatu, Brazil
  • Clinical Trial Site — Bragança Paulista, Brazil
  • Clinical Trial Site — Brasília, Brazil
  • Clinical Trial Site — Brasília, Brazil
  • Clinical Trial Site — Campina Grande do Sul, Brazil
  • Clinical Trial Site — Campinas, Brazil
  • Clinical Trial Site — Campinas, Brazil
  • Clinical Trial Site — Colatina, Brazil
  • Clinical Trial Site — Curitiba, Brazil
  • Clinical Trial Site — Curitiba, Brazil
  • Clinical Trial Site — Fortaleza, Brazil
  • Clinical Trial Site — Fortaleza, Brazil
  • Clinical Trial Site — Joinville, Brazil
  • Clinical Trial Site — Joinville, Brazil
  • Clinical Trial Site — Maceió, Brazil
  • Clinical Trial Site — Natal, Brazil
  • Clinical Trial Site — Porto Alegre, Brazil
  • Clinical Trial Site — Porto Alegre, Brazil
  • Clinical Trial Site — Porto Alegre, Brazil
  • Clinical Trial Site — Porto Alegre, Brazil
  • Clinical Trial Site — Porto Alegre, Brazil
  • Clinical Trial Site — Porto Alegre, Brazil
  • Clinical Trial Site — Rio de Janeiro, Brazil
  • Clinical Trial Site — Rio de Janeiro, Brazil
  • Clinical Trial Site — Salvador, Brazil
  • Clinical Trial Site — Salvador, Brazil
  • Clinical Trial Site — Salvador, Brazil
  • Clinical Trial Site — Salvador, Brazil
  • Clinical Trial Site — Santo André, Brazil
  • Clinical Trial Site — São Bernardo do Campo, Brazil
  • Clinical Trial Site — São José, Brazil
  • Clinical Trial Site — São José do Rio Preto, Brazil
  • Clinical Trial Site — São José dos Campos, Brazil
  • Clinical Trial Site — São Paulo, Brazil
  • Clinical Trial Site — São Paulo, Brazil
  • Clinical Trial Site — São Paulo, Brazil
  • Clinical Trial Site — São Paulo, Brazil
  • Clinical Trial Site — São Paulo, Brazil
  • Clinical Trial Site — São Paulo, Brazil
  • Clinical Trial Site — São Paulo, Brazil
  • Clinical Trial Site — Sorocaba, Brazil
  • Clinical Trial Site — Tatuí, Brazil
  • Clinical Trial Site — Vitória, Brazil
  • Clinical Trial Site — Blagoevgrad, Bulgaria
  • Clinical Trial Site — Botevgrad, Bulgaria
  • Clinical Trial Site — Burgas, Bulgaria
  • Clinical Trial Site — Burgas, Bulgaria
  • Clinical Trial Site — Burgas, Bulgaria
  • Clinical Trial Site — Burgas, Bulgaria
  • Clinical Trial Site — Dimitrovgrad, Bulgaria
  • Clinical Trial Site — Gabrovo, Bulgaria
  • Clinical Trial Site — Haskovo, Bulgaria
  • Clinical Trial Site — Montana, Bulgaria
  • Clinical Trial Site — Pleven, Bulgaria
  • Clinical Trial Site — Pleven, Bulgaria
  • Clinical Trial Site — Plovdiv, Bulgaria
  • Clinical Trial Site — Plovdiv, Bulgaria
  • Clinical Trial Site — Plovdiv, Bulgaria
  • Clinical Trial Site — Rousse, Bulgaria
  • Clinical Trial Site — Rousse, Bulgaria
  • Clinical Trial Site — Rousse, Bulgaria
  • Clinical Trial Site — Rousse, Bulgaria
  • Clinical Trial Site — Sliven, Bulgaria
  • Clinical Trial Site — Smolyan, Bulgaria
  • Clinical Trial Site — Sofia, Bulgaria
  • Clinical Trial Site — Sofia, Bulgaria
  • Clinical Trial Site — Sofia, Bulgaria
  • Clinical Trial Site — Sofia, Bulgaria
  • Clinical Trial Site — Sofia, Bulgaria
  • Clinical Trial Site — Sofia, Bulgaria
  • Clinical Trial Site — Sofia, Bulgaria
  • Clinical Trial Site — Sofia, Bulgaria
  • Clinical Trial Site — Sofia, Bulgaria
  • Clinical Trial Site — Sofia, Bulgaria
  • Clinical Trial Site — Sofia, Bulgaria
  • Clinical Trial Site — Sofia, Bulgaria
  • Clinical Trial Site — Sofia, Bulgaria
  • Clinical Trial Site — Sofia, Bulgaria
  • Clinical Trial Site — Sofia, Bulgaria
  • Clinical Trial Site — Stara Zagora, Bulgaria
  • Clinical Trial Site — Stara Zagora, Bulgaria
  • Clinical Trial Site — Varna, Bulgaria
  • Clinical Trial Site — Veliko Tarnovo, Bulgaria
  • Clinical Trial Site — Veliko Tarnovo, Bulgaria
  • Clinical Trial Site — Veliko Tarnovo, Bulgaria
  • Clinical Trial Site — Brampton, Canada
  • Clinical Trial Site — Brampton, Canada
  • Clinical Trial Site — Burlington, Canada
  • Clinical Trial Site — Cambridge, Canada
  • Clinical Trial Site — Chicoutimi, Canada
  • Clinical Trial Site — Etobicoke, Canada
  • Clinical Trial Site — Etobicoke, Canada
  • Clinical Trial Site — Greater Sudbury, Canada
  • Clinical Trial Site — Laval, Canada
  • Clinical Trial Site — Lévis, Canada
  • Clinical Trial Site — London, Canada
  • Clinical Trial Site — Longueuil, Canada
  • Clinical Trial Site — Mirabel, Canada
  • Clinical Trial Site — Mississauga, Canada
  • Clinical Trial Site — Moncton, Canada
  • Clinical Trial Site — Moncton, Canada
  • Clinical Trial Site — Montreal, Canada
  • Clinical Trial Site — Montreal, Canada
  • Clinical Trial Site — Peterborough, Canada
  • Clinical Trial Site — Québec, Canada
  • Clinical Trial Site — Québec, Canada
  • Clinical Trial Site — Québec, Canada
  • Clinical Trial Site — Richmond, Canada
  • Clinical Trial Site — Rimouski, Canada
  • Clinical Trial Site — Saint-Jérôme, Canada
  • Clinical Trial Site — Sarnia, Canada
  • Clinical Trial Site — Scarborough, Canada
  • Clinical Trial Site — Scarborough, Canada
  • Clinical Trial Site — Sherbrooke, Canada
  • Clinical Trial Site — Sherbrooke, Canada
  • Clinical Trial Site — Sydney, Canada
  • Clinical Trial Site — Trois-Rivières, Canada
  • Clinical Trial Site — Windsor, Canada
  • Clinical Trial Site — Independencia, Chile
  • Clinical Trial Site — Independencia, Chile
  • Clinical Trial Site — Osorno, Chile
  • Clinical Trial Site — Santiago, Chile
  • Clinical Trial Site — Santiago, Chile
  • Clinical Trial Site — Santiago, Chile
  • Clinical Trial Site — Santiago, Chile
  • Clinical Trial Site — Temuco, Chile
  • Clinical Trial Site — Valdivia, Chile
  • Clinical Trial Site — Beijing, China
  • Clinical Trial Site — Beijing, China
  • Clinical Trial Site — Binhai, China
  • Clinical Trial Site — Changchun, China
  • Clinical Trial Site — Changchun, China
  • Clinical Trial Site — Changsha, China
  • Clinical Trial Site — Changsha, China
  • Clinical Trial Site — Changsha, China
  • Clinical Trial Site — Chengdu, China
  • Clinical Trial Site — Chengdu, China
  • Clinical Trial Site — Chenzhou, China
  • Clinical Trial Site — Chifeng, China
  • Clinical Trial Site — Chongqing, China
  • Clinical Trial Site — Dalian, China
  • Clinical Trial Site — Dalian, China
  • Clinical Trial Site — Datong, China
  • Clinical Trial Site — Foshan, China
  • Clinical Trial Site — Fuzhou, China
  • Clinical Trial Site — Guangzhou, China
  • Clinical Trial Site — Guangzhou, China
  • Clinical Trial Site — Haidian, China
  • Clinical Trial Site — Haikou, China
  • Clinical Trial Site — Haikou, China
  • Clinical Trial Site — Handan, China
  • Clinical Trial Site — Hangzhou, China
  • Clinical Trial Site — Hangzhou, China
  • Clinical Trial Site — Hangzhou, China
  • Clinical Trial Site — Hangzhou, China
  • Clinical Trial Site — Hefei, China
  • Clinical Trial Site — Hefei, China
  • Clinical Trial Site — Huaian, China
  • Clinical Trial Site — Huainan, China
  • Clinical Trial Site — Jiaxing, China
  • Clinical Trial Site — Jinan, China
  • Clinical Trial Site — Jinan, China
  • Clinical Trial Site — Kaifeng, China
  • Clinical Trial Site — Kunming, China
  • Clinical Trial Site — Kunming, China
  • Clinical Trial Site — Lanzhou, China
  • Clinical Trial Site — Lianyungang, China
  • Clinical Trial Site — Lishui, China
  • Clinical Trial Site — Luoyang, China
  • Clinical Trial Site — Luzhou, China
  • Clinical Trial Site — Nanchang, China
  • Clinical Trial Site — Nanchang, China
  • Clinical Trial Site — Nanchang, China
  • Clinical Trial Site — Nanjing, China
  • Clinical Trial Site — Nanyang, China
  • Clinical Trial Site — Pingxiang, China
  • Clinical Trial Site — Shanghai, China
  • Clinical Trial Site — Shanghai, China
  • Clinical Trial Site — Shenyang, China
  • Clinical Trial Site — Shenyang, China
  • Clinical Trial Site — Shijiazhuang, China
  • Clinical Trial Site — Shijiazhuang, China
  • Clinical Trial Site — Shijiazhuang, China
  • Clinical Trial Site — Taian, China
  • Clinical Trial Site — Taiyuan, China
  • Clinical Trial Site — Taiyuan, China
  • Clinical Trial Site — Tangshan, China
  • Clinical Trial Site — Tianjin, China
  • Clinical Trial Site — Tianjin, China
  • Clinical Trial Site — Ürümqi, China
  • Clinical Trial Site — Ürümqi, China
  • Clinical Trial Site — Wenzhou, China
  • Clinical Trial Site — Wuhan, China
  • Clinical Trial Site — Wuhan, China
  • Clinical Trial Site — Wuhan, China
  • Clinical Trial Site — Xianyang, China
  • Clinical Trial Site — Xinxiang, China
  • Clinical Trial Site — Xuancheng, China
  • Clinical Trial Site — Xuzhou, China
  • Clinical Trial Site — Xuzhou, China
  • Clinical Trial Site — Yangzhou, China
  • Clinical Trial Site — Yantai, China
  • Clinical Trial Site — Yuncheng, China
  • Clinical Trial Site — Zhenjiang, China
  • Clinical Trial Site — Zibo, China
  • Clinical Trial Site — Armenia, Colombia
  • Clinical Trial Site — Barranquilla, Colombia
  • Clinical Trial Site — Barranquilla, Colombia
  • Clinical Trial Site — Barranquilla, Colombia
  • Clinical Trial Site — Barranquilla, Colombia
  • Clinical Trial Site — Bogotá, Colombia
  • Clinical Trial Site — Bogotá, Colombia
  • Clinical Trial Site — Cartagena, Colombia
  • Clinical Trial Site — Medellín, Colombia
  • Clinical Trial Site — Medellín, Colombia
  • Clinical Trial Site — Medellín, Colombia
  • Clinical Trial Site — Puerto Colombia, Colombia
  • Clinical Trial Site — Zipaquirá, Colombia
  • Clinical Trial Site — Benešov, Czechia
  • Clinical Trial Site — Bílina, Czechia
  • Clinical Trial Site — Brno, Czechia
  • Clinical Trial Site — Brno, Czechia
  • Clinical Trial Site — Brno, Czechia
  • Clinical Trial Site — Brno, Czechia
  • Clinical Trial Site — Brno, Czechia
  • Clinical Trial Site — Chlumec nad Cidlinou, Czechia
  • Clinical Trial Site — Hodonín, Czechia
  • Clinical Trial Site — Krnov, Czechia
  • Clinical Trial Site — Mariánské Lázně, Czechia
  • Clinical Trial Site — Olomouc, Czechia
  • Clinical Trial Site — Ostrava, Czechia
  • Clinical Trial Site — Ostrava, Czechia
  • Clinical Trial Site — Ostrava, Czechia
  • Clinical Trial Site — Ostrava, Czechia
  • Clinical Trial Site — Ostrava, Czechia
  • Clinical Trial Site — Ostrava, Czechia
  • Clinical Trial Site — Pardubice, Czechia
  • Clinical Trial Site — Prague, Czechia
  • Clinical Trial Site — Prague, Czechia
  • Clinical Trial Site — Prague, Czechia
  • Clinical Trial Site — Prague, Czechia
  • Clinical Trial Site — Prague, Czechia
  • Clinical Trial Site — Prague, Czechia
  • Clinical Trial Site — Prague, Czechia
  • Clinical Trial Site — Příbram, Czechia
  • Clinical Trial Site — Slaný, Czechia
  • Clinical Trial Site — Zlín, Czechia
  • Clinical Trial Site — Esbjerg, Denmark
  • Clinical Trial Site — Holbæk, Denmark
  • Clinical Trial Site — Hvidovre, Denmark
  • Clinical Trial Site — København S, Denmark
  • Clinical Trial Site — Odense, Denmark
  • Clinical Trial Site — Vejle, Denmark
  • Clinical Trial Site — Auxerre, France
  • Clinical Trial Site — Bobigny, France
  • Clinical Trial Site — Bordeaux, France
  • Clinical Trial Site — Caen, France
  • Clinical Trial Site — Nîmes, France
  • Clinical Trial Site — Paris, France
  • Clinical Trial Site — Pau, France
  • Clinical Trial Site — Poitiers, France
  • Clinical Trial Site — Reims, France
  • Clinical Trial Site — Rouen, France
  • Clinical Trial Site — Saint-Herblain, France
  • Clinical Trial Site — Valenciennes, France
  • Clinical Trial Site — Aachen, Germany
  • Clinical Trial Site — Ahaus, Germany
  • Clinical Trial Site — Altenburg, Germany
  • Clinical Trial Site — Bad Homburg, Germany
  • Clinical Trial Site — Berlin, Germany
  • Clinical Trial Site — Berlin, Germany
  • Clinical Trial Site — Berlin, Germany
  • Clinical Trial Site — Berlin, Germany
  • Clinical Trial Site — Berlin, Germany
  • Clinical Trial Site — Berlin, Germany
  • Clinical Trial Site — Brandenburg an der Havel, Germany
  • Clinical Trial Site — Bremen, Germany
  • Clinical Trial Site — Cologne, Germany
  • Clinical Trial Site — Dachau, Germany
  • Clinical Trial Site — Deggingen, Germany
  • Clinical Trial Site — Dortmund, Germany
  • Clinical Trial Site — Dresden, Germany
  • Clinical Trial Site — Duisburg, Germany
  • Clinical Trial Site — Düsseldorf, Germany
  • Clinical Trial Site — Elsterwerda, Germany
  • Clinical Trial Site — Erfurt, Germany
  • Clinical Trial Site — Essen, Germany
  • Clinical Trial Site — Frankfurt am Main, Germany
  • Clinical Trial Site — Frankfurt am Main, Germany
  • Clinical Trial Site — Gelnhausen, Germany
  • Clinical Trial Site — Hamburg, Germany
  • Clinical Trial Site — Hamburg, Germany
  • Clinical Trial Site — Hanover, Germany
  • Clinical Trial Site — Heidelberg, Germany
  • Clinical Trial Site — Hohenmölsen, Germany
  • Clinical Trial Site — Jerichow, Germany
  • Clinical Trial Site — Kaiserslautern, Germany
  • Clinical Trial Site — Kiel, Germany
  • Clinical Trial Site — Konstanz, Germany
  • Clinical Trial Site — Langen, Germany
  • Clinical Trial Site — Leipzig, Germany
  • Clinical Trial Site — Leipzig, Germany
  • Clinical Trial Site — Magdeburg, Germany
  • Clinical Trial Site — Mönchengladbach, Germany
  • Clinical Trial Site — Mühldorf, Germany
  • Clinical Trial Site — Offenbach, Germany
  • Clinical Trial Site — Papenburg, Germany
  • Clinical Trial Site — Pirna, Germany
  • Clinical Trial Site — Reinfeld, Germany
  • Clinical Trial Site — Saint Ingbert, Germany
  • Clinical Trial Site — Stuhr, Germany
  • Clinical Trial Site — Villingen-Schwenningen, Germany
  • Clinical Trial Site — Wallerfing, Germany
  • Clinical Trial Site — Wermsdorf, Germany
  • Clinical Trial Site — Zwenkau, Germany
  • Clinical Trial Site — Ampelokipoi, Greece
  • Clinical Trial Site — Athens, Greece
  • Clinical Trial Site — Athens, Greece
  • Clinical Trial Site — Chaïdári, Greece
  • Clinical Trial Site — Chios, Greece
  • Clinical Trial Site — Heraklion, Greece
  • Clinical Trial Site — Heraklion, Greece
  • Clinical Trial Site — Ioannina, Greece
  • Clinical Trial Site — Kalyftaki-N. Kifissia, Greece
  • Clinical Trial Site — Kifissia, Greece
  • Clinical Trial Site — Larissa, Greece
  • Clinical Trial Site — Marousi, Greece
  • Clinical Trial Site — Marousi, Greece
  • Clinical Trial Site — N. Efkapria-Pavlos Melas, Greece
  • Clinical Trial Site — Nea Ionia, Greece
  • Clinical Trial Site — Nikaia, Greece
  • Clinical Trial Site — Pátrai, Greece
  • Clinical Trial Site — Pylaia, Greece
  • Clinical Trial Site — Thessaloniki, Greece
  • Clinical Trial Site — Thessaloniki, Greece
  • Clinical Trial Site — Voula, Greece
  • Clinical Trial Site — Baja, Hungary
  • Clinical Trial Site — Balatonfüred, Hungary
  • Clinical Trial Site — Békéscsaba, Hungary
  • Clinical Trial Site — Budapest, Hungary
  • Clinical Trial Site — Budapest, Hungary
  • Clinical Trial Site — Budapest, Hungary
  • Clinical Trial Site — Budapest, Hungary
  • Clinical Trial Site — Budapest, Hungary
  • Clinical Trial Site — Budapest, Hungary
  • Clinical Trial Site — Budapest, Hungary
  • Clinical Trial Site — Budapest, Hungary
  • Clinical Trial Site — Budapest, Hungary
  • Clinical Trial Site — Debrecen, Hungary
  • Clinical Trial Site — Gyöngyös, Hungary
  • Clinical Trial Site — Hódmezovásárhely, Hungary
  • Clinical Trial Site — Kecskemét, Hungary
  • Clinical Trial Site — Kistarcsa, Hungary
  • Clinical Trial Site — Komárom, Hungary
  • Clinical Trial Site — Nyíregyháza, Hungary
  • Clinical Trial Site — Nyíregyháza, Hungary
  • Clinical Trial Site — Orosháza, Hungary
  • Clinical Trial Site — Orosháza, Hungary
  • Clinical Trial Site — Pécs, Hungary
  • Clinical Trial Site — Szeged, Hungary
  • Clinical Trial Site — Szeged, Hungary
  • Clinical Trial Site — Szekszárd, Hungary
  • Clinical Trial Site — Székesfehérvár, Hungary
  • Clinical Trial Site — Zalaegerszeg, Hungary
  • Clinical Trial Site — Ahmedabad, India
  • Clinical Trial Site — Belagavi, India
  • Clinical Trial Site — Bhāratnagar, India
  • Clinical Trial Site — Chhatrapati Sambhajinagar, India
  • Clinical Trial Site — Coimbatore, India
  • Clinical Trial Site — Dehradun, India
  • Clinical Trial Site — Guntur, India
  • Clinical Trial Site — Gurugram, India
  • Clinical Trial Site — Hyderabad, India
  • Clinical Trial Site — Hyderabad, India
  • Clinical Trial Site — Hyderabad, India
  • Clinical Trial Site — Jaipur, India
  • Clinical Trial Site — Jaipur, India
  • Clinical Trial Site — Jaipur, India
  • Clinical Trial Site — Kanpur, India
  • Clinical Trial Site — Kochi, India
  • Clinical Trial Site — Kochi, India
  • Clinical Trial Site — Kozhikode, India
  • Clinical Trial Site — Lucknow, India
  • Clinical Trial Site — Mahamoorganj, India
  • Clinical Trial Site — Mysuru, India
  • Clinical Trial Site — Nagpur, India
  • Clinical Trial Site — Nagpur, India
  • Clinical Trial Site — Nagpur, India
  • Clinical Trial Site — Nashik, India
  • Clinical Trial Site — Nashik, India
  • Clinical Trial Site — New Delhi, India
  • Clinical Trial Site — New Delhi, India
  • Clinical Trial Site — Raipur, India
  • Clinical Trial Site — Shivamogga, India
  • Clinical Trial Site — Sola, India
  • Clinical Trial Site — Surat, India
  • Clinical Trial Site — Thane, India
  • Clinical Trial Site — Vadodara, India
  • Clinical Trial Site — Visakhapatnam, India
  • Clinical Trial Site — Ancona, Italy
  • Clinical Trial Site — Bologna, Italy
  • Clinical Trial Site — Cittadella, Italy
  • Clinical Trial Site — Lecco, Italy
  • Clinical Trial Site — L’Aquila, Italy
  • Clinical Trial Site — Messina, Italy
  • Clinical Trial Site — Milan, Italy
  • Clinical Trial Site — Milan, Italy
  • Clinical Trial Site — Naples, Italy
  • Clinical Trial Site — Naples, Italy
  • Clinical Trial Site — Novara, Italy
  • Clinical Trial Site — Palermo, Italy
  • Clinical Trial Site — Pisa, Italy
  • Clinical Trial Site — Potenza, Italy
  • Clinical Trial Site — Pozzilli, Italy
  • Clinical Trial Site — Roma, Italy
  • Clinical Trial Site — San Benedetto del Tronto, Italy
  • Clinical Trial Site — Siena, Italy
  • Clinical Trial Site — Sora, Italy
  • Clinical Trial Site — Terni, Italy
  • Clinical Trial Site — Torino, Italy
  • Clinical Trial Site — Varese, Italy
  • Clinical Trial Site — Bunkyō City, Japan
  • Clinical Trial Site — Chikushino-shi, Japan
  • Clinical Trial Site — Chūōku, Japan
  • Clinical Trial Site — Chūōku, Japan
  • Clinical Trial Site — Chūōku, Japan
  • Clinical Trial Site — Fukuoka, Japan
  • Clinical Trial Site — Fukuoka, Japan
  • Clinical Trial Site — Hachioji-Shi, Japan
  • Clinical Trial Site — Hachiōji, Japan
  • Clinical Trial Site — Hakodate-Shi, Japan
  • Clinical Trial Site — Hakodate-Shi, Japan
  • Clinical Trial Site — Hakusan, Japan
  • Clinical Trial Site — Himeji, Japan
  • Clinical Trial Site — Izumi, Japan
  • Clinical Trial Site — Kasuga, Japan
  • Clinical Trial Site — Kita-ku, Japan
  • Clinical Trial Site — Kusatsu, Japan
  • Clinical Trial Site — Minamiku, Japan
  • Clinical Trial Site — Minato, Japan
  • Clinical Trial Site — Nagaoka-Shi, Japan
  • Clinical Trial Site — Nagasaki, Japan
  • Clinical Trial Site — Okayama, Japan
  • Clinical Trial Site — Osaka, Japan
  • Clinical Trial Site — Osaka, Japan
  • Clinical Trial Site — Osaka, Japan
  • Clinical Trial Site — Osaka, Japan
  • Clinical Trial Site — Ōta-ku, Japan
  • Clinical Trial Site — Saku, Japan
  • Clinical Trial Site — Sakura-Shi, Japan
  • Clinical Trial Site — Sapporo, Japan
  • Clinical Trial Site — Sapporo, Japan
  • Clinical Trial Site — Sendai, Japan
  • Clinical Trial Site — Shimotsuke-shi, Japan
  • Clinical Trial Site — Shinagawa-Ku, Japan
  • Clinical Trial Site — Shinjuku-Ku, Japan
  • Clinical Trial Site — Shinjuku-ku, Japan
  • Clinical Trial Site — Suita, Japan
  • Clinical Trial Site — Tamanashi, Japan
  • Clinical Trial Site — Yokohama, Japan
  • Clinical Trial Site — Yokosuka, Japan
  • Clinical Trial Site — Aguascalientes, Mexico
  • Clinical Trial Site — Apizaco, Mexico
  • Clinical Trial Site — Chihuahua City, Mexico
  • Clinical Trial Site — Durango, Mexico
  • Clinical Trial Site — Guadalajara, Mexico
  • Clinical Trial Site — Mexico City, Mexico
  • Clinical Trial Site — 's-Hertogenbosch, Netherlands
  • Clinical Trial Site — Alkmaar, Netherlands
  • Clinical Trial Site — Amersfoort, Netherlands
  • Clinical Trial Site — Amsterdam, Netherlands
  • Clinical Trial Site — Doetinchem, Netherlands
  • Clinical Trial Site — Ede, Netherlands
  • Clinical Trial Site — Goes, Netherlands
  • Clinical Trial Site — Hoogeveen, Netherlands
  • Clinical Trial Site — Hoorn, Netherlands
  • Clinical Trial Site — Nijmegen, Netherlands
  • Clinical Trial Site — Utrecht, Netherlands
  • Clinical Trial Site — Auckland, New Zealand
  • Clinical Trial Site — Christchurch, New Zealand
  • Clinical Trial Site — Ebdentown, New Zealand
  • Clinical Trial Site — Hamilton, New Zealand
  • Clinical Trial Site — Silverdale, New Zealand
  • Clinical Trial Site — Takapuna, New Zealand
  • Clinical Trial Site — Wellington, New Zealand
  • Clinical Trial Site — Bialystok, Poland
  • Clinical Trial Site — Bydgoszcz, Poland
  • Clinical Trial Site — Bydgoszcz, Poland
  • Clinical Trial Site — Bydgoszcz, Poland
  • Clinical Trial Site — Chojnice, Poland
  • Clinical Trial Site — Chorzów, Poland
  • Clinical Trial Site — Chrzanów, Poland
  • Clinical Trial Site — Częstochowa, Poland
  • Clinical Trial Site — Dębica, Poland
  • Clinical Trial Site — Gdansk, Poland
  • Clinical Trial Site — Gdansk, Poland
  • Clinical Trial Site — Gdansk, Poland
  • Clinical Trial Site — Gdynia, Poland
  • Clinical Trial Site — Gdynia, Poland
  • Clinical Trial Site — Gdynia, Poland
  • Clinical Trial Site — Giżycko, Poland
  • Clinical Trial Site — Grodzisk Mazowiecki, Poland
  • Clinical Trial Site — Jaksice, Poland
  • Clinical Trial Site — Katowice, Poland
  • Clinical Trial Site — Katowice, Poland
  • Clinical Trial Site — Katowice, Poland
  • Clinical Trial Site — Katowice, Poland
  • Clinical Trial Site — Katowice, Poland
  • Clinical Trial Site — Katowice, Poland
  • Clinical Trial Site — Kędzierzyn-Koźle, Poland
  • Clinical Trial Site — Krakow, Poland
  • Clinical Trial Site — Krakow, Poland
  • Clinical Trial Site — Krakow, Poland
  • Clinical Trial Site — Krakow, Poland
  • Clinical Trial Site — Krakow, Poland
  • Clinical Trial Site — Lodz, Poland
  • Clinical Trial Site — Lodz, Poland
  • Clinical Trial Site — Lodz, Poland
  • Clinical Trial Site — Lublin, Poland
  • Clinical Trial Site — Lublin, Poland
  • Clinical Trial Site — Lublin, Poland
  • Clinical Trial Site — Lublin, Poland
  • Clinical Trial Site — Malbork, Poland
  • Clinical Trial Site — Myszków, Poland
  • Clinical Trial Site — Olsztyn, Poland
  • Clinical Trial Site — Ostrowiec Świętokrzyski, Poland
  • Clinical Trial Site — Piotrkow Trybunalski, Poland
  • Clinical Trial Site — Poznan, Poland
  • Clinical Trial Site — Poznan, Poland
  • Clinical Trial Site — Poznan, Poland
  • Clinical Trial Site — Ruda Śląska, Poland
  • Clinical Trial Site — Rybnik, Poland
  • Clinical Trial Site — Rzeszów, Poland
  • Clinical Trial Site — Siedlce, Poland
  • Clinical Trial Site — Skierniewice, Poland
  • Clinical Trial Site — Sopot, Poland
  • Clinical Trial Site — Staszów, Poland
  • Clinical Trial Site — Świdnik, Poland
  • Clinical Trial Site — Tarnów, Poland
  • Clinical Trial Site — Torun, Poland
  • Clinical Trial Site — Ustroń, Poland
  • Clinical Trial Site — Warsaw, Poland
  • Clinical Trial Site — Warsaw, Poland
  • Clinical Trial Site — Warsaw, Poland
  • Clinical Trial Site — Warsaw, Poland
  • Clinical Trial Site — Warsaw, Poland
  • Clinical Trial Site — Warsaw, Poland
  • Clinical Trial Site — Warsaw, Poland
  • Clinical Trial Site — Warsaw, Poland
  • Clinical Trial Site — Warsaw, Poland
  • Clinical Trial Site — Warsaw, Poland
  • Clinical Trial Site — Wroclaw, Poland
  • Clinical Trial Site — Wroclaw, Poland
  • Clinical Trial Site — Wroclaw, Poland
  • Clinical Trial Site — Wroclaw, Poland
  • Clinical Trial Site — Zamość, Poland
  • Clinical Trial Site — Almada, Portugal
  • Clinical Trial Site — Baixa Da Banheira, Portugal
  • Clinical Trial Site — Carnaxide, Portugal
  • Clinical Trial Site — Coimbra, Portugal
  • Clinical Trial Site — Coimbra, Portugal
  • Clinical Trial Site — Creixomil, Portugal
  • Clinical Trial Site — Leiria, Portugal
  • Clinical Trial Site — Lisbon, Portugal
  • Clinical Trial Site — Lisbon, Portugal
  • Clinical Trial Site — Lisbon, Portugal
  • Clinical Trial Site — Loures, Portugal
  • Clinical Trial Site — Ponte de Lima, Portugal
  • Clinical Trial Site — Riachos, Portugal
  • Clinical Trial Site — Santa Maria da Feira, Portugal
  • Clinical Trial Site — Senhora da Hora, Portugal
  • Clinical Trial Site — Setúbal, Portugal
  • Clinical Trial Site — Touguinhó, Portugal
  • Clinical Trial Site — Viana do Castelo, Portugal
  • Clinical Trial Site — Vila Nova de Gaia, Portugal
  • Clinical Trial Site — Baia Mare, Romania
  • Clinical Trial Site — Baia Mare, Romania
  • Clinical Trial Site — Brasov, Romania
  • Clinical Trial Site — Brasov, Romania
  • Clinical Trial Site — Bucharest, Romania
  • Clinical Trial Site — Bucharest, Romania
  • Clinical Trial Site — Bucharest, Romania
  • Clinical Trial Site — Buzău, Romania
  • Clinical Trial Site — Cluj-Napoca, Romania
  • Clinical Trial Site — Craiova, Romania
  • Clinical Trial Site — Craiova, Romania
  • Clinical Trial Site — Iași, Romania
  • Clinical Trial Site — Iași, Romania
  • Clinical Trial Site — Oradea, Romania
  • Clinical Trial Site — Oradea, Romania
  • Clinical Trial Site — Ploieşti, Romania
  • Clinical Trial Site — Satu Mare, Romania
  • Clinical Trial Site — Sibiu, Romania
  • Clinical Trial Site — Târgu Mureş, Romania
  • Clinical Trial Site — Târgu Mureş, Romania
  • Clinical Trial Site — Timișoara, Romania
  • Clinical Trial Site — Timișoara, Romania
  • Clinical Trial Site — Timișoara, Romania
  • Clinical Trial Site — Timișoara, Romania
  • Clinical Trial Site — Belgrade, Serbia
  • Clinical Trial Site — Belgrade, Serbia
  • Clinical Trial Site — Ćuprija, Serbia
  • Clinical Trial Site — Kamenitz, Serbia
  • Clinical Trial Site — Kragujevac, Serbia
  • Clinical Trial Site — Leskovac, Serbia
  • Clinical Trial Site — Niš, Serbia
  • Clinical Trial Site — Niška Banja, Serbia
  • Clinical Trial Site — Zaječar, Serbia
  • Clinical Trial Site — Zrenjanin, Serbia
  • Clinical Trial Site — Bardejov, Slovakia
  • Clinical Trial Site — Bratislava, Slovakia
  • Clinical Trial Site — Bratislava, Slovakia
  • Clinical Trial Site — Bratislava, Slovakia
  • Clinical Trial Site — Bratislava, Slovakia
  • Clinical Trial Site — Bratislava, Slovakia
  • Clinical Trial Site — Brezno, Slovakia
  • Clinical Trial Site — Ilava, Slovakia
  • Clinical Trial Site — Košice, Slovakia
  • Clinical Trial Site — Košice, Slovakia
  • Clinical Trial Site — Lučenec, Slovakia
  • Clinical Trial Site — Moldava nad Bodvou, Slovakia
  • Clinical Trial Site — Nitra, Slovakia
  • Clinical Trial Site — Prešov, Slovakia
  • Clinical Trial Site — Stará Turá, Slovakia
  • Clinical Trial Site — Vinica, Slovakia
  • Clinical Trial Site — Belville, South Africa
  • Clinical Trial Site — Bloemfontein, South Africa
  • Clinical Trial Site — Bloemfontein, South Africa
  • Clinical Trial Site — Cape Town, South Africa
  • Clinical Trial Site — Cape Town, South Africa
  • Clinical Trial Site — Cape Town, South Africa
  • Clinical Trial Site — Chatsworth, South Africa
  • Clinical Trial Site — City of Johannesburg, South Africa
  • Clinical Trial Site — Durban, South Africa
  • Clinical Trial Site — Durban, South Africa
  • Clinical Trial Site — Durban, South Africa
  • Clinical Trial Site — Durban, South Africa
  • Clinical Trial Site — Ekurhuleni, South Africa
  • Clinical Trial Site — Ekurhuleni, South Africa
  • Clinical Trial Site — Ekurhuleni, South Africa
  • Clinical Trial Site — Gauteng, South Africa
  • Clinical Trial Site — Johannesburg, South Africa
  • Clinical Trial Site — Johannesburg, South Africa
  • Clinical Trial Site — Johannesburg, South Africa
  • Clinical Trial Site — Johannesburg, South Africa
  • Clinical Trial Site — KwaDukuza, South Africa
  • Clinical Trial Site — KwaZulu - Natal, South Africa
  • Clinical Trial Site — Mogale City, South Africa
  • Clinical Trial Site — Mossel Bay, South Africa
  • Clinical Trial Site — Nelson Mandela Bay, South Africa
  • Clinical Trial Site — Plettenberg Bay, South Africa
  • Clinical Trial Site — Pretoria, South Africa
  • Clinical Trial Site — Pretoria, South Africa
  • Clinical Trial Site — Pretoria, South Africa
  • Clinical Trial Site — Soweto, South Africa
  • Clinical Trial Site — Worcester, South Africa
  • Clinical Trial Site — Anyang-si, South Korea
  • Clinical Trial Site — Busan, South Korea
  • Clinical Trial Site — Changwon-si, South Korea
  • Clinical Trial Site — Cheongju-si, South Korea
  • Clinical Trial Site — Daegu, South Korea
  • Clinical Trial Site — Daejeon, South Korea
  • Clinical Trial Site — Goyang-si, South Korea
  • Clinical Trial Site — Gwangju, South Korea
  • Clinical Trial Site — Gwangju, South Korea
  • Clinical Trial Site — Gwangmyeong, South Korea
  • Clinical Trial Site — Jeju City, South Korea
  • Clinical Trial Site — Jeonju, South Korea
  • Clinical Trial Site — Seongnam-si, South Korea
  • Clinical Trial Site — Seoul, South Korea
  • Clinical Trial Site — Seoul, South Korea
  • Clinical Trial Site — Seoul, South Korea
  • Clinical Trial Site — Seoul, South Korea
  • Clinical Trial Site — Seoul, South Korea
  • Clinical Trial Site — Seoul, South Korea
  • Clinical Trial Site — Seoul, South Korea
  • Clinical Trial Site — Seoul, South Korea
  • Clinical Trial Site — Seoul, South Korea
  • Clinical Trial Site — Seoul, South Korea
  • Clinical Trial Site — Seoul, South Korea
  • Clinical Trial Site — Wŏnju, South Korea
  • Clinical Trial Site — A Coruña, Spain
  • Clinical Trial Site — Alcalá de Henares, Spain
  • Clinical Trial Site — Alicante, Spain
  • Clinical Trial Site — Antequera, Spain
  • Clinical Trial Site — Badajoz, Spain
  • Clinical Trial Site — Barcelona, Spain
  • Clinical Trial Site — Barcelona, Spain
  • Clinical Trial Site — Barcelona, Spain
  • Clinical Trial Site — Barcelona, Spain
  • Clinical Trial Site — Barcelona, Spain
  • Clinical Trial Site — Burjassot, Spain
  • Clinical Trial Site — Cadiz, Spain
  • Clinical Trial Site — Centelles, Spain
  • Clinical Trial Site — Córdoba, Spain
  • Clinical Trial Site — El Palmar, Spain
  • Clinical Trial Site — Figueres, Spain
  • Clinical Trial Site — Girona, Spain
  • Clinical Trial Site — Huelva, Spain
  • Clinical Trial Site — Jaén, Spain
  • Clinical Trial Site — L'Hospitalet de Llobregat, Spain
  • Clinical Trial Site — Lugo, Spain
  • Clinical Trial Site — Madrid, Spain
  • Clinical Trial Site — Madrid, Spain
  • Clinical Trial Site — Madrid, Spain
  • Clinical Trial Site — Madrid, Spain
  • Clinical Trial Site — Marbella, Spain
  • Clinical Trial Site — Málaga, Spain
  • Clinical Trial Site — Palma de Mallorca, Spain
  • Clinical Trial Site — Pamplona, Spain
  • Clinical Trial Site — Peralada, Spain
  • Clinical Trial Site — Pozuelo de Alarcón, Spain
  • Clinical Trial Site — Salamanca, Spain
  • Clinical Trial Site — San Sebastián de los Reyes, Spain
  • Clinical Trial Site — Santiago de Compostela, Spain
  • Clinical Trial Site — Santiago de Compostela, Spain
  • Clinical Trial Site — Segovia, Spain
  • Clinical Trial Site — Seville, Spain
  • Clinical Trial Site — Seville, Spain
  • Clinical Trial Site — Seville, Spain
  • Clinical Trial Site — Tarragona, Spain
  • Clinical Trial Site — Torrejón de Ardoz, Spain
  • Clinical Trial Site — Valencia, Spain
  • Clinical Trial Site — Valencia, Spain
  • Clinical Trial Site — Valladolid, Spain
  • Clinical Trial Site — Vigo, Spain
  • Clinical Trial Site — Gothenburg, Sweden
  • Clinical Trial Site — Stockholm, Sweden
  • Clinical Trial Site — Uppsala, Sweden
  • Clinical Trial Site — Hualien City, Taiwan
  • Clinical Trial Site — Kaohsiung City, Taiwan
  • Clinical Trial Site — New Taipei City, Taiwan
  • Clinical Trial Site — New Taipei City, Taiwan
  • Clinical Trial Site — Tainan, Taiwan
  • Clinical Trial Site — Taipei, Taiwan
  • Clinical Trial Site — Taipei, Taiwan
  • Clinical Trial Site — Taipei, Taiwan
  • Clinical Trial Site — Taipei, Taiwan
  • Clinical Trial Site — Taipei, Taiwan
  • Clinical Trial Site — Taoyuan City, Taiwan
  • Clinical Trial Site — Eskişehir, Turkey (Türkiye)
  • Clinical Trial Site — Istanbul, Turkey (Türkiye)
  • Clinical Trial Site — Istanbul, Turkey (Türkiye)
  • Clinical Trial Site — Istanbul, Turkey (Türkiye)
  • Clinical Trial Site — Izmir, Turkey (Türkiye)
  • Clinical Trial Site — Kocaeli, Turkey (Türkiye)
  • Clinical Trial Site — Konya, Turkey (Türkiye)
  • Clinical Trial Site — Muratpaşa, Turkey (Türkiye)
  • Clinical Trial Site — Sivas, Turkey (Türkiye)
  • Clinical Trial Site — Ashburton, United Kingdom
  • Clinical Trial Site — Belfast, United Kingdom
  • Clinical Trial Site — Bellshill, United Kingdom
  • Clinical Trial Site — Birmingham, United Kingdom
  • Clinical Trial Site — Birmingham, United Kingdom
  • Clinical Trial Site — Bristol, United Kingdom
  • Clinical Trial Site — Bristol, United Kingdom
  • Clinical Trial Site — Bury St Edmunds, United Kingdom
  • Clinical Trial Site — Cambridge, United Kingdom
  • Clinical Trial Site — Cardiff, United Kingdom
  • Clinical Trial Site — Cardiff, United Kingdom
  • Clinical Trial Site — Chichester, United Kingdom
  • Clinical Trial Site — Corby, United Kingdom
  • Clinical Trial Site — Darlington, United Kingdom
  • Clinical Trial Site — Dorchester, United Kingdom
  • Clinical Trial Site — Ely, United Kingdom
  • Clinical Trial Site — Fowey, United Kingdom
  • Clinical Trial Site — Glasgow, United Kingdom
  • Clinical Trial Site — Heston, United Kingdom
  • Clinical Trial Site — Honiton, United Kingdom
  • Clinical Trial Site — Ilford, United Kingdom
  • Clinical Trial Site — Isleworth, United Kingdom
  • Clinical Trial Site — Leeds, United Kingdom
  • Clinical Trial Site — Liskeard, United Kingdom
  • Clinical Trial Site — Liverpool, United Kingdom
  • Clinical Trial Site — Liverpool, United Kingdom
  • Clinical Trial Site — London, United Kingdom
  • Clinical Trial Site — London, United Kingdom
  • Clinical Trial Site — Luton, United Kingdom
  • Clinical Trial Site — Manchester, United Kingdom
  • Clinical Trial Site — Manchester, United Kingdom
  • Clinical Trial Site — Metropolitan Borough of Wirral, United Kingdom
  • Clinical Trial Site — Middlesbrough, United Kingdom
  • Clinical Trial Site — Milton Keynes, United Kingdom
  • Clinical Trial Site — Newquay, United Kingdom
  • Clinical Trial Site — Northallerton, United Kingdom
  • Clinical Trial Site — Penzance, United Kingdom
  • Clinical Trial Site — Plymouth, United Kingdom
  • Clinical Trial Site — Plympton, United Kingdom
  • Clinical Trial Site — Poole, United Kingdom
  • Clinical Trial Site — Redhill, United Kingdom
  • Clinical Trial Site — Sale, United Kingdom
  • Clinical Trial Site — Swansea, United Kingdom
  • Clinical Trial Site — Swindon, United Kingdom
  • Clinical Trial Site — Teeside, United Kingdom
  • Clinical Trial Site — Thetford, United Kingdom
  • Clinical Trial Site — Torpoint, United Kingdom
  • Clinical Trial Site — Wolverhampton, United Kingdom
  • Clinical Trial Site — York, United Kingdom
Sponsored

Partner with Nurenyx

Showcase your study to thousands of motivated patients matching your criteria.

Learn More

Official Source

Data sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

View Official Record